VALVECURE, LLC

Outpatient cardiology transcatheter annuloplasty via RF energy to tighten the mitral valve biologically to eliminate regurgitation without an implant.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Boston, MA, USA
  • Currency USD
  • Founded March 2013
  • Employees 0
  • Incorporation Type LLC
  • Website valvecure.com

Company Summary

Cardiovascular device technology, specifically addressing a therapy to cure functional mitral and tricuspid regurgitation. Our technologies have successfully undergone pre-clinical testing, and we are seeking funding to fulfill clinical testing, "First-In-Man". Additional IP in the structural heart space. NOTE: Series A round funding commitments finalized for complete closing 4th quarter 2023.

Team

Previous Investors

  • Cardiologists, Cardio-thoracic surgeons and industry business angels.
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free